A phase II trial of pevonedistat plus docetaxel in patients with previously treated advanced non–small-cell lung cancer (NSCLC)
Wells, Leah, Qin, Angel, Rice, John, Gadgeel, Shirish M., Schneider, Bryan J., Ramnath, Nithya, Zhao, Lili, Kalemkerian, Gregory Peter
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
The impact of COVID-19 and armed conflict on cancer care in Armenia: A cross-sectional study
Margaryan, Yeva, Hambardzumyan, Liana, Aghabekyan, Tigran, Kalemkerian, Gregory Peter, Danielyan, Samvel, Muradyan, Armen, Tamamyan, Gevorg, Arakelyan, Stella
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
A phase I/II multisite study of rucaparib and pembrolizumab maintenance therapy in stage IV non-squamous non–small cell lung cancer after initial therapy with carboplatin, pemetrexed, and pembrolizumab
Qin, Angel, Morgensztern, Daniel, Waqar, Saiama Naheed, Owen, Dwight Hall, Gadgeel, Shirish M., Kalemkerian, Gregory Peter, Zhao, Lili, Ramnath, Nithya
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Enhancing thoracic oncology in Armenia: Impact of the implementation of an expert-guided virtual multidisciplinary tumor board
Zohrabyan, Davit, Karapetyan, Nune, Tamamyan, Gevorg, Safaryan, Liana, Bardakhchyan, Samvel, Karamyan, Sona, Ghayamyan, Meri, Khachatryan, Mariam, Danielyan, Samvel, Rushanyan, Marine, Mkrtchyan, Gohar, Harutyunyan, Martin, Sargsyan, Amalya, Mailyan, Mariam, Gharadaghyan, Hovsep, Mkhitaryan, Benik, Avagyan, Hayk, Baloyan, Elen, Shaverdian, Narek, Kalemkerian, Gregory Peter
Published in Journal of clinical oncology (01.06.2024)
Published in Journal of clinical oncology (01.06.2024)
Get full text
Journal Article
Exploratory biomarker analysis of the phase 3 KEYNOTE-604 study of pembrolizumab plus etoposide for extensive-stage SCLC
Rudin, Charles M., Kim, Hye Ryun, Navarro, Alejandro, Gottfried, Maya, Peters, Solange, Csoszi, Tibor, Cheema, Parneet Kaur, Rodriguez-Abreu, Delvys, Wollner, Mira, Yang, James Chih-Hsin, Mazieres, Julien, Kato, Terufumi, Kalemkerian, Gregory Peter, Dettman, Elisha, Edmondson, Mackenzie, Vajdi, Amir, Loboda, Andrey, El-Osta, Hazem Edmond, Zhao, Bin, Awad, Mark M.
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Trial in progress: A multicenter phase Ib/II study of pelcitoclax (APG-1252) in combination with paclitaxel in patients with relapsed/refractory small-cell lung cancer (R/R SCLC)
Qin, Angel, Kalemkerian, Gregory Peter, Patel, Jyoti D., Mohindra, Nisha Anjali, Carlisle, Jennifer W, Sands, Jacob, He, Zhicong, Winkler, Robert, Liang, Zhiyan, Hammock, Vakessa, Bombelli, Riccardo, Lu, Ming, Xu, Yang, Fu, Tommy, Wang, Cunlin, Yang, Dajun, Zhai, Yifan
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
First-in-human study of pelcitoclax (APG-1252) in combination with paclitaxel in patients (pts) with relapsed/refractory small-cell lung cancer (R/R SCLC)
Qin, Angel, Kalemkerian, Gregory Peter, Mohindra, Nisha Anjali, Patel, Jyoti D., Karapetis, Christos Stelios, Carlisle, Jennifer W, Sands, Jacob, Spira, Alexander I., Gao, Bo, Amin, Harshad, Paudyal, Bishnuhari, Frank, Genevieve, Sun, Xuemei, Xu, Yang, Wang, Cunlin, Fu, Tommy, Winkler, Robert, Liang, Zhiyan, Yang, Dajun, Zhai, Yifan
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
A phase II trial of nintedanib in recurrent malignant pleural mesothelioma (MPM)
Wozniak, Antoinette J., Schneider, Bryan J., Kalemkerian, Gregory Peter, Daly, Robert Michael, Chen, Wei, Ventimiglia, Jaclyn, Nagasaka, Misako, Zauderer, Marjorie Glass
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
Clinical activity and safety of the RET inhibitor pralsetinib in patients with RET fusion-positive solid tumors: Update from the ARROW trial
Subbiah, Vivek, Cassier, Philippe A., Siena, Salvatore, Alonso, Guzman, Paz-Ares, Luis G., Garrido, Pilar, Nadal, Ernest, Curigliano, Giuseppe, Vuky, Jacqueline, Lopes, Gilberto, Kalemkerian, Gregory Peter, Bowles, Daniel W., Seetharam, Mahesh, Chang, Jianhua, Zhang, Hui, Ye, Chaoyang, Green, Jennifer, Zalutskaya, Alena, Schuler, Martin H., Fan, Yun
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
Safety and efficacy of pralsetinib in patients with advanced RET fusion-positive non-small cell lung cancer: Update from the ARROW trial
Curigliano, Giuseppe, Gainor, Justin F., Griesinger, Frank, Thomas, Michael, Subbiah, Vivek, Baik, Christina S, Tan, Daniel Shao-Weng, Lee, Dae Ho, Misch, Daniel, Garralda, Elena, Kim, Dong-Wan, Paz-Ares, Luis G., Mazieres, Julien, Liu, Stephen V., Kalemkerian, Gregory Peter, Houvras, Yariv, Bowles, Daniel W., Mansfield, Aaron Scott, Zalutskaya, Alena, van der Wekken, Anthonie J.
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
KEYNOTE-604: Pembrolizumab (pembro) or placebo plus etoposide and platinum (EP) as first-line therapy for extensive-stage (ES) small-cell lung cancer (SCLC)
Rudin, Charles M., Awad, Mark M., Navarro, Alejandro, Gottfried, Maya, Peters, Solange, Csőszi, Tibor, Cheema, Parneet Kaur, Rodriguez-Abreu, Delvys, Wollner, Mira, Czyzewicz, Grzegorz, Yang, James Chih-Hsin, Mazieres, Julien, Orlandi, Francisco J, Luft, Alexander, Gumus, Mahmut, Kato, Terufumi, Kalemkerian, Gregory Peter, Luo, Yiwen, Pietanza, Maria Catherine, Kim, Hye Ryun
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Patterns of disease progression in advanced non-small cell lung cancer patients treated with PD-1 inhibitors
Qin, Angel, Kalemkerian, Gregory Peter, Schneider, Bryan J., Hassan, Khaled Aref, Cease, Kemp Bailey, Zhao, Lili, Warren, Edus H., Ramnath, Nithya
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
Phase II study of maintenance pembrolizumab (pembro) in extensive stage small cell lung cancer (ES-SCLC) patients (pts)
Gadgeel, Shirish M., Ventimiglia, Jaclyn, Kalemkerian, Gregory Peter, Fidler, Mary J., Chen, Wei, Sukari, Ammar, Halmos, Balazs, Boerner, Julie, Wozniak, Antoinette J., Galasso, Cathy, Pennell, Nathan A.
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
A phase I study of cediranib (NSC #732208) in combination with cisplatin and pemetrexed in chemonaive patients with malignant pleural mesothelioma (SWOG S0905)
Tsao, Anne S., Moon, James, Wistuba, Ignacio Ivan, Vogelzang, Nicholas J., Kalemkerian, Gregory Peter, Redman, Mary Weber, Gandara, David R.
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article
Total mutation burden (TMB) in lung cancer (LC) and relationship with response to PD-1/PD-L1 targeted therapies
Spigel, David R., Schrock, Alexa Betzig, Fabrizio, David, Frampton, Garrett Michael, Sun, James, He, Jie, Gowen, Kyle, Johnson, Melissa Lynne, Bauer, Todd Michael, Kalemkerian, Gregory Peter, Raez, Luis E., Ou, Sai-Hong Ignatius, Ross, Jeffrey S., Stephens, Philip J., Miller, Vincent A., Ali, Siraj Mahamed
Published in Journal of clinical oncology (20.05.2016)
Published in Journal of clinical oncology (20.05.2016)
Get full text
Journal Article
Radiographic parameters in predicting outcome of patients with nonsquamous non-small cell lung cancer (NSCLC) treated with bevacizumab
Kaufman, Michael R, Salem, Mohamed E., Aoun, Hussein, Kalemkerian, Gregory Peter, Kunz, Sara, El-Refai, Sherif, Ranganath, Praveen, Sukari, Ammar, Gadgeel, Shirish M., Wozniak, Antoinette J.
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article
Retrospective analysis of the impact of age on overall survival in patients with non-small cell lung cancer
Luu, Dai Chu Nguyen, Mamet, Rizvan, Zornosa, Carrie C., Niland, Joyce C., D'Amico, Thomas A., Kalemkerian, Gregory Peter, Koczywas, Marianna, Pisters, Katherine, Rabin, Michael S., Otterson, Gregory Alan
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article
A phase II trial of mid-treatment FDG-PET adaptive, individualized radiation therapy plus concurrent chemotherapy in patients with non-small cell lung cancer (NSCLC)
Kong, Fengming, Ten Haken, Randall K, Schipper, Matthew J, Hayman, James, Ramnath, Nithya, Hassan, Khaled Aref, Matuszak, Martha, Ritter, Timothy, Bi, Nan, Wang, Weili, Orringer, Mark, Cease, Kemp Bailey, Lawrence, Theodore Steven, Kalemkerian, Gregory Peter
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article